CSIMarket


Aligos Therapeutics Inc   (ALGS)
Other Ticker:  
 

Aligos Therapeutics Inc

ALGS's Fundamental analysis








Aligos Therapeutics Inc 's sales fell by -21.12 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 477

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -7.98 %

Aligos Therapeutics Inc net loss deacreased by in III. Quarter 2023 year on year, Aligos Therapeutics Inc net loss increased by -3.11 % in III. Quarter 2023 year on year,

More on ALGS's Growth


Aligos Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 0.46 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.52.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.72.


More on ALGS's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.26

Aligos Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 0.46 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.52.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.72.

Aligos Therapeutics Inc Price to Book Ratio is at 0.75 lower than Indusry Avg. of 885.84. and higher than S&P 500 Avg. of -2060.44

More on ALGS's Valuation

  Market Capitalization (Millions $) 41
  Shares Outstanding (Millions) 44
  Employees -
  Revenues (TTM) (Millions $) 16
  Net Income (TTM) (Millions $) -82
  Cash Flow (TTM) (Millions $) 90
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 1.26

  Market Capitalization (Millions $) 41
  Shares Outstanding (Millions) 44
  Employees -
  Revenues (TTM) (Millions $) 16
  Net Income (TTM) (Millions $) -82
  Cash Flow (TTM) (Millions $) 90
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 3.32
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.57
  Asset Turnover Ratio (TTM) 0.14
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com